SLC2A1 and neoplasm: Its mechanisms of action involve apoptosis induction, immune system modulation, and disruption of key oncogenic signaling pathways, including the inhibition of glucose transport via GLUT1 and suppression of JAK2/STAT3 signaling, thereby impeding tumor growth and metastasis.